Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,863,543
  • Shares Outstanding, K 46,471
  • Annual Sales, $ 1,361 M
  • Annual Income, $ 167,680 K
  • EBIT $ 285 M
  • EBITDA $ 415 M
  • 60-Month Beta 0.36
  • Price/Sales 2.23
  • Price/Cash Flow 8.34
  • Price/Book 3.06

Options Overview Details

View History
  • Implied Volatility 55.76% (+7.62%)
  • Historical Volatility 30.25%
  • IV Percentile 83%
  • IV Rank 66.28%
  • IV High 72.27% on 10/21/25
  • IV Low 23.32% on 03/17/26
  • Expected Move (DTE 24) 3.26 (5.32%)
  • Put/Call Vol Ratio 1.00
  • Today's Volume 4
  • Volume Avg (30-Day) 100
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 3,420
  • Open Int (30-Day) 2,591
  • Expected Range 57.91 to 64.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.28
  • Number of Estimates 6
  • High Estimate $1.31
  • Low Estimate $1.26
  • Prior Year $1.24
  • Growth Rate Est. (year over year) +3.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.88 +13.53%
on 03/27/26
62.78 -2.56%
on 04/16/26
+2.59 (+4.42%)
since 03/20/26
3-Month
53.88 +13.53%
on 03/27/26
73.00 -16.21%
on 01/21/26
-8.93 (-12.74%)
since 01/20/26
52-Week
47.31 +29.28%
on 09/26/25
87.32 -29.95%
on 12/10/25
+4.00 (+7.00%)
since 04/17/25

Most Recent Stories

More News
1 Value Stock on Our Buy List and 2 Facing Headwinds

1 Value Stock on Our Buy List and 2 Facing Headwinds

COLL : 34.31 (-0.29%)
HAE : 61.17 (-0.73%)
WT : 18.30 (+4.81%)
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

BOSTON , April 1, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter fiscal year 2026 financial results at 6:00 am ET on Thursday,...

HAE : 61.17 (-0.73%)
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies

HAE : 61.17 (-0.73%)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

WERN : 33.50 (+2.82%)
HHH : 67.45 (+2.29%)
HAE : 61.17 (-0.73%)
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

ZTS : 122.72 (+0.71%)
HAE : 61.17 (-0.73%)
ELV : 319.36 (-1.14%)
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

HAE : 61.17 (-0.73%)
3 Reasons HAE is Risky and 1 Stock to Buy Instead

3 Reasons HAE is Risky and 1 Stock to Buy Instead

HAE : 61.17 (-0.73%)
3 Profitable Stocks with Open Questions

3 Profitable Stocks with Open Questions

ASGN : 40.04 (+1.52%)
GPC : 112.59 (-1.05%)
HAE : 61.17 (-0.73%)
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

BOSTON , Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...

HAE : 61.17 (-0.73%)
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

BOSTON , Feb. 20, 2026 /PRNewswire/ --  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James...

HAE : 61.17 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 63.60
2nd Resistance Point 62.88
1st Resistance Point 62.02
Last Price 61.17
1st Support Level 60.44
2nd Support Level 59.72
3rd Support Level 58.86

See More

52-Week High 87.32
Fibonacci 61.8% 72.04
Fibonacci 50% 67.32
Fibonacci 38.2% 62.60
Last Price 61.17
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.